Email
Print
Stem Cell Banking Market- By Source , By Service Type, By Application , By Geography - Global Opportunity Analysis & Industry Forecast, 2024 - 2030
Stem Cell Banking Market Overview
The Stem Cell Banking Market Size is forecast to reach $ 12679 Million by 2030, at a CAGR of 6.80% during forecast period 2024-2030. Stem cells have been the most researched topic in the field of science. Stem cells are the body's raw materials and possess the capability to draw themselves into specific blood cells which exhibit specialized functions. Stem cells can be recovered from various methods, such as embryonic stem cells. The cells harvested during in-vitro fertilization and in the count is close to 150. They can be divided into any type of cells, as earlier discussed. Moreover, stem cells can be divided into daughter cells, and daughter cells can further be divided into new stem cells (with self-renewal) properties or can become specialized cells. Stem cell therapy has been a ready source of cure for hematopoietic disorders such as rare genetic disorders, anemia, HIV, and others. The ongoing research in stem cells has the capability to understand how diseases occur, and various conditions develop. Cord tissue banking has been adopted as the potential method to store life-saving stem cells for any future injuries or chronic diseases. The advent of regenerative medicines and the use of stem cells to check quality and safety before releasing a new batch of drugs have been key factors driving the stem cell banking industry forward in the projected period of 2024-2030.
Report Coverage
The report: "Stem Cell Banking Market Forecast (2024-2030)" by Industry ARC covers an in-depth analysis of the following segments of the Stem Cell Banking Market.
Key Takeaways
- Geographically, North America's stem cell banking held a dominant market share in the year 2020. It is owing to the advent of various genetic disorders and the rise in the use of regenerative medicines. Additionally, the region is seeing an inflated flow of funds for development pertaining to the pharmaceutical and biotechnology sector which has readily aided the market growth. However, Asia-Pacific is set to grow at a lucrative pace in the projected period. It is owing to the development of new-age start-ups which thereby allows for the opening of various stem cell banking systems using advanced healthcare technology such as IoT.
- The growing awareness pertaining to the use of therapeutic potential stem cells has been a key driver for the market. However, high operational costs and maintenance fees are some of the reasons the market is facing friction and poses a challenge.
- A detailed analysis of strengths, weaknesses, opportunities, and threats will be provided in the stem cell banking market report.
Stem Cell Banking Market- Geography (%) for 2020.
For more details on this report - Request for Sample
Stem Cell Banking Market Segmentation Analysis- By Source
The stem cell banking market based on the source can be further segmented into Placental Stem Cell, Adipose-Tissue Derived Stem Cells, Bone Marrow-Derived Stem Cells, Human Embryo Derived Stem Cell, Dental Pulp Derived Stem Cells and Others. The Bone marrow-derived stem cells held a dominant market share in the year 2020. It is owing to its standard use in the treatment of cancer cases such as leukemia, myeloma, and various others. Bone marrow-derived stem cells are also considered privileged immune cells, as they do not portray immunogenic properties and hence are used in patients who then do not need immunosuppression. Moreover, there are close to 4300 bone marrow and cord blood transplants recorded in 2018, while nearly 23 million potential donors are available.
However, Human Embryo Stem cells are estimated to be the fastest-growing, with a CAGR of 8.4% over the forecast period of 2021-2026. The embryonic stem cell is obtained potentially after 3-5 days, and it has about 150 cells. Moreover, the following pluripotent stem cells have the capability to divide into more stem cells or become any form of cell. Their versatility has allowed the researchers to use them in various applications pertaining to regenerative medicines or to especially regenerate a diseased tissue or organ.
Stem Cell Banking Market Segmentation Analysis- By Application
The stem cell banking based on the application can be further segmented into Personalized Banking, Research Applications, and Clinical Applications. Personalized banking held a dominant market share in the year 2020. It is owing to the various benefits now being co-offered with availing services. The service provider has curated various flexible payment plans to later the financial burden on the end-user. For example, Cord Blood Registry has payment plans starting from as low as $49/month. Additionally, they have started promoting themselves under "highest recovery rate- up to 99%", which readily appeals to the public's confidence, as recovery is often a worry in cases of stem cell banking.
Moreover, personalized banking is estimated to be the fastest-growing, with a CAGR of 8.6% over the forecast period of 2021-2026. The advent of insurance policies in the service provider has proved out to be a game-changer. Sample banking companies reimburse in cased of failed graft, however owing to competition, the bankers have really notched up their payback rates. For example, Ameri-Cord now pays around $110,000 as insurance, with no monthly storage fees and cancellation fees. The following methodology would drive the segment forward.
Stem Cell Banking Market Segmentation Analysis- By Geography
The Stem Cell Banking Market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America's stem cell banking held a dominant market share of 42% as compared to the other regions in 2020. It is owing to the rising cases of cancers and other neurodegenerative diseases in the region. For example, in the U.S., approximately 1.9 million were diagnosed with Cancer; moreover, post-cancer stem cell therapy is often recommended as it helps in restoring the damaged cells. The cells are damaged owing to chemotherapy and other forms. Along with that, the incidence of Parkinson's disease is high in the country, and the ongoing research has helped the market of stem cell banking across various applications.
However, Asia-Pacific is set to offer lucrative market opportunities to marketers in the projected period of 2021-2026. It is owing to a steady rise in the new players opting for facilities such as stem cell banking. Additionally, governmental agencies have supported the start-up culture in the health care domain, which allows for the development of new drugs, which again supports the growth of stem cells. These factors would help in the growth of the following region.
Stem Cell Banking Market Drivers
The use of stem cell therapy or regenerative medicines has readily aided market growth.
Stem cell therapy has often been conferred as the next chapter after organ transplantation. As they are termed regenerative medicines, they promote repair response in the diseased cells. The following cells are used instead of donor’s organs, as they have the potential to provide a healthy line of cells that are free of any disease or infection. Researchers grow these cells in their labs and are thereby manipulated to form other forms of distinctive cells. For example, if a patient is suffering from heart disease, then they can be used and injected into the heart muscle. The healthy line of cells could repair the defective heart cells and contribute to a better life expectancy. Stem cell therapy can readily suffice the demand and supply gap between organ transplants. For example, the demand for a kidney transplant in the USA was close to 100,000; however, only close to 20,000 people received the transplant. The demand for the remaining can be catered by stem cell therapy, and hence, grow the stem cell banking market.
The lateral increase in auto-immune diseases and the elongated use of stem cells to check for effectiveness in new drugs have readily aided the growth of the market.
Stem cell therapy has shown results in treating those afflicted with spinal cord injuries, suffering from type 1 diabetes, Parkinson’s disease, and various other rare diseases. As per Parkinson’s Organization, approximately more than 60,000 cases of the disease are added in the USA. Moreover, there are currently more than one million-plus active cases of the disease in the demography. Researchers are readily studying the use of stem cell therapy in the treatment of Parkinson’s disease. Stem cells can be directly injected into the brains of people, and a doctor must make a small incision and inject stem cells where the neurotransmitter dopamine is found. The process can take hold and thereby start producing dopamine which is negligible in the person suffering from Parkinson’s disease. Lastly, the cost of such treatment would be on the lower side and hence allow more people to take advantage of it.
Stem Cell Banking Market Challenges
The operational cost pertaining to storage and other facilities has acted as a market challenge.
The stem cells or the embryonic stem cells are often derived from the umbilical cord. A lot of competition has already been in place for the market. However, the cost of storing stem cells in a bank remains a primary concern. The pricing for storing cord tissue or stem cells, on average, can cost $4000/ a year. Additionally, facilities always face the risk of losing the sample’s integrity owing to various physical constraints. The reagents, consumables, and other instruments are charged on premium, which in turn increases the per-person cost. The process for acquiring licenses has been another challenge as regulatory bodies follow a stringent approach. Hence, the number of providers and new entrants are not many, and hence poses a market challenge.
Stem Cell Banking Market Competitive Landscape
Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the stem cell banking. The top 10- stem cell banking market companies include:
- Cord Blood Registry
- Americord
- CryoCell
- StemCyte
- Viacord
- Lifebank USA
- Miracle Cord
- Maze Cord Blood
- CryoHoldco
- CordLife Group Limited
Stem Cell Banking Market Developments
- In September 2021, The California Institute for Regenerative Medicines awarded $31 million to Stanford Researchers. The amount is granted to study stem cells and conduct the first-in-human trials of stem cells to treat stroke, heart failure, and other forms of neurodegenerative diseases. The $31 million is divided into various other purposes, for example, $12 million would allow for the study, whether after therapy with stem cell one can regain mobility. The second study, in which $ 12 million would be used to study CAR-T cell therapy. Another, $7 million is to be used to study stem cells’ ability to help in aiding heart failures.
- In January 2020, Life-Cell launched community stem cell banking services in India. The enterprise would be known as Baby Cord Share. The purpose of the launch was to allow for the ready availability of finding a matching donor in a challenging environment. The price to avail of the services is kept at INR 17000, while an annual maintenance fee of INR 4,000 would be charged from the customer.
Key Market Players:
The Top 5 companies in Stem Cell Banking Market are:
- CBR
- Cryo-Cell International
- ViaCord
- LifeCell
- Americord